IL278149B2
Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both waysCites: the store holds 3 of 4
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO03097873A2 | Cites | World Intellectual Property Organization (WIPO) | – | Search report | – |
| WO03100091A1 | Cites | World Intellectual Property Organization (WIPO) | – | Search report | – |
| WO2009108837A2 | Cites | World Intellectual Property Organization (WIPO) | X | Search report | 1-3,7-20 |
| DUCCI, FRANCESCA, ET AL., HTR3B IS ASSOCIATED WITH ALCOHOLISM WITH ANTISOCIAL BEHAVIOR AND ALPHA EEG POWER—AN INTERMEDIATE PHENOTYPE FOR ALCOHOLISM AND CO-MORBID BEHAVIORS., 1 February 2009 (2009-02-01) | Non-patent | – | – | Search report | – |
| GU, BO, ET AL., ASSOCIATION BETWEEN A POLYMORPHISM OF THE HTR3A GENE AND THERAPEUTIC RESPONSE TO RISPERIDONE TREATMENT IN DRUG-NAIVE CHINESE SCHIZOPHRENIA PATIENTS., 1 August 2008 (2008-08-01) | Non-patent | – | – | Search report | – |
| SOUZA, RENAN P., ET AL., INFLUENCE OF SEROTONIN 3A AND 3B RECEPTOR GENES ON CLOZAPINE TREATMENT RESPONSE IN SCHIZOPHRENIA., 4 April 2010 (2010-04-04) | Non-patent | – | – | Search report | – |
58 members in 18 offices
Priority claims7
| Document | Office | Kind | Date |
|---|---|---|---|
| 36120310 | United States of America | P | |
| 61361203 | United States of America | – | |
| 201161429416 | United States of America | P | |
| 61429416 | United States of America | – | |
| 201161488328 | United States of America | P | |
| 61488328 | United States of America | – | |
| 2011042823 | United States of America | W |
Members58
| Document | Office | Kind | |
|---|---|---|---|
| CA2804174A1 | Canada | A1 | |
| WO2012003462A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2012003462A4 | World Intellectual Property Organization (WIPO) | A4 | |
| WO2012162268A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2013012559A1 | United States of America | A1 | |
| AU2011274355A1 | Australia | A1 | |
| EP2588630A1 | European Patent Office (EPO) | A1 | |
| US2013125950A1 | United States of America | A1 | |
| EA201390017A1 | Eurasian Patent Organization (EAPO) | A1 | |
| WO2012162268A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP2588630A4 | European Patent Office (EPO) | A4 | |
| AU2012258898A1 | Australia | A1 | |
| KR20140008531A | Republic of Korea | A | |
| EP2710639A2 | European Patent Office (EPO) | A2 | |
| US8753815B2 | United States of America | B2 | |
| NZ605709A | New Zealand | A | |
| US2014288139A1 | United States of America | A1 | |
| KR101449891B1 | Republic of Korea | B1 | |
| EP2801625A1 | European Patent Office (EPO) | A1 | |
| AU2015200219A1 | Australia | A1 | |
| NZ621352A | New Zealand | A | |
| NZ621356A | New Zealand | A | |
| EP2710639A4 | European Patent Office (EPO) | A4 | |
| EA024450B1 | Eurasian Patent Organization (EAPO) | B1 | |
| AU2011274355B2 | Australia | B2 | |
| US9539242B2 | United States of America | B2 | |
| US2017239222A1 | United States of America | A1 | |
| US9748414B2 | United States of America | B2 | |
| EP2801625B1 | European Patent Office (EPO) | B1 | |
| DK2801625T3 | Denmark | T3 | |
| LT2801625T | Lithuania | T | |
| HRP20180193T1 | Croatia | T1 | |
| ES2664083T3 | Spain | T3 | |
| UA116615C2 | Ukraine | C2 | |
| SI2801625T1 | Slovenia | T1 | |
| HUE035574T2 | Hungary | T2 | |
| PL2801625T3 | Poland | T3 | |
| CY1120057T1 | Cyprus | T1 | |
| IL262874D0 | Israel | D0 | |
| US10603307B2 | United States of America | B2 | |
| US2020316028A1 | United States of America | A1 | |
| IL278149A | Israel | A | |
| IL278149D0 | Israel | D0 | |
| US2021023058A1 | United States of America | A1 | |
| IL262874A | Israel | A | |
| IL262874B | Israel | B | |
| US11116753B2 | United States of America | B2 | |
| US11324723B2 | United States of America | B2 | |
| US2023014787A1 | United States of America | A1 | |
| US2023241032A1 | United States of America | A1 | |
| US2023263776A1 | United States of America | A1 | |
| IL278149B1 | Israel | B1 | |
| IL278149B2This record | Israel | B2 | |
| US11957664B2 | United States of America | B2 | |
| US2024277671A1 | United States of America | A1 | |
| US12150931B2 | United States of America | B2 | |
| US12226401B2 | United States of America | B2 | |
| US12274692B2 | United States of America | B2 |
Numbers
- Publication
- 278149
- Application
- 278149
Titles2
- English
- MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE
- Hebrew
- גישה גנטית מוליקולרית לטיפול ואבחון של תלות באלכוהול וסמים
Classification
- CPC, 12
- C12Q1/6883
- A61K31/4178
- C12Q2600/106
- A61P25/30
- C12Q2600/172
- G16B20/00
- A61P25/34
- A61K31/7048
- A61P25/32
- C12Q1/6888
- A61P25/36
- C12Q2600/156
- IPC, 9
- A61K31 4178
- A61K31 7048
- A61P25 30
- A61P25 32
- A61P25 34
- A61P25 36
- G16B20 00
- C12Q1 6883
- C12Q1 6888